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Signaling

via

the

conserved

WNT/β-CATENIN

pathway

controls

diverse

developmental processes. To explore its potential role in the ovary, we investigated the
expression of WNTs, frizzled (FZD) receptors, and other pathway components in
human cumulus cells obtained from oocytes collected for in vitro fertilization. Proteins
30

were detected in cultured cells using immunofluorescence microscopy. Protein-protein
interactions were analyzed by means of immunoprecipitation. WNT2, FZD2, FZD3,
and FZD9 were identified but WNT1, WNT4 and FZD4 were not detected. WNT2 is
co-expressed with FZD2, FZD3, and FZD9. Co-immunoprecipitation using WNT2
antibody demonstrated that WNT2 interacts with both FZD3 and FZD9, but only
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FZD9 antibody precipitated WNT2. We also identified DVL (disheveled), AXIN,
GSK-3β (glycogen synthase kinase-3β), and β-CATENIN. β-CATENIN is
concentrated in the plasma membranes. DVL co-localizes with FZD9 and AXIN in the
membranes, but GSK-3β has little colocalization with AXIN and β-CATENIN.
Interestingly, β-CATENIN is highly co-localized with FZD9 and AXIN. CDH1
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(E-cadherin) was also detected in the plasma membranes and cytoplasm, co-localized
with β-CATENIN, and CDH1 antibody precipitated β-CATENIN. The results suggest
that WNT2 could act through its receptor FZD9 to regulate the β-CATENIN pathway
in cumulus cells, recruiting β-CATENIN into plasma membranes and promoting the
formation of adherens junctions involving CDH1.
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Introduction
WNT genes encode a large family of secreted, cysteine-rich glycoproteins that have
been implicated in a variety of cellular processes, such as cell fate specification, cell
50

proliferation, differentiation, survival and apoptosis, polarity, and migration (Wodarz
and Nusse, 1998; Hoppler and Kavanagh, 2007). Dysregulation of WNT signaling has
been found to cause developmental defects and tumorigenesis (Logan and Nusse,
2004). To date, 19 WNT members have been identified in human. Frizzled (FZD)
receptors are a family of seven-transmembrane proteins, 10 of which are encoded in

55

the human genome. The N-terminal extracellular cysteine-rich domain (CRD) has
been identified as the WNT-binding domain (Dann et al., 2001). The WNT-FZD
relationship is well characterized in Drosophila, however, the specificity of WNT-FZD
interactions remains largely unresolved in vertebrates because of the large number of
WNT and FZD genes and the numerous possibilities for WNT-FZD interactions and
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functional redundancies (Rulifson et al., 2000; Hsieh et al., 1999).
The canonical WNT pathway is well understood for its ability to regulate cell-cell
adhesion and cell cycle control, and β-CATENIN is the central and essential
component in this pathway (Mulholland et al., 2005). In the absence of WNT
activation, β-CATENIN is tightly regulated through phosphorylation at specific
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N-terminal residues by a destruction complex that includes casein kinase-1α (CK1α),
glycogen synthase kinase-3 (GSK3), along with tumor suppressors adenomatous
polyposis coli (APC) and AXIN. Phosphorylated β-CATENIN is targeted for rapid
ubiquitinylation and degradation in the 26S proteasome (Gordon and Nusse, 2006;
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Habas and Dawid, 2005). Disheveled (DVL) is, at present, the only known key
70

intermediate connecting FZD and the downstream β-CATENIN pathway, and may
bind directly to the FZD C-terminal region via a PDZ domain (Wong et al., 2003).
Following WNT binding to the receptor complex consisting of FZD and lipoprotein
receptor-related protein 5 and 6 (LRP5/6), the activation of the phosphoprotein DVL
recruits AXIN and the destruction complex to the plasma membrane. AXIN is then
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degraded by proteasomes, which decreases β-CATENIN degradation. The activation
of DVL also leads to the destabilization of the destruction complex and inhibition of
GSK3, which further reduces the phosphorylation and degradation of β-CATENIN
(Gordon and Nusse, 2006; Moon et al., 2004). As a result, hypophosphorylated
β-CATENIN accumulates in the cytoplasm and is translocated to the nucleus where it
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interacts with the T-cell factor and lymphoid enhancer-binding factor (TCF/LEF)
family of transcription factors to activate the transcription of target genes (Gordon and
Nusse, 2006). In addition to its function in the WNT pathway, β-CATENIN also
functions as a key component of the cadherin complex, which controls cell-cell
adhesion and influences cell migration (Bienz, 2005; Nelson and Nusse, 2004).
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Ovarian folliculogenesis requires complex regulatory mechanisms involving both
endocrine and intra-ovarian signaling pathways. Recently, WNT signaling has been
implicated in ovarian development, oogenesis, and early development. Wnt4 deficient
mice exhibit sex reversal and a paucity of oocytes in the newborn ovary, while mice
null for Fzd4 are infertile and exhibit impaired function of the corpus luteum (Vionio et
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al., 1999; Hsieh et al., 2005). Multiple Wnt transcripts are localized in the different
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compartments of the mouse ovary: Wnt2 and Fzd1 are expressed in the granulosa cells
while Wnt4 and Fzd4 are expressed in the corpus luteum (Ricken et al., 2002; Hsieh et
al., 2002). It has been reported that misregulation of WNT/β-CATENIN signaling in
granulosa cells can contribute to granulosa cell tumor development (Boerboom et al.,
95

2005).
The preovulatory oocyte is surrounded by several cell layers, known as the
cumulus granulosa cells, which are metabolically coupled with each other and the
oocyte through intercellular membrane channels (gap junctions) that facilitate
exchange of small signaling molecules between the cells (Laird, 2006). The cumulus
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cells exhibit hormone responsiveness, a gene expression profile, and intercellular
signaling distinct from those of the mural (outer) granulosa cell layers, which
contribute to the oocyte through the final stage of its development (Russell and Robker,
2007). However, very little is known about the expression or function of the
WNT/β-CATENIN signaling pathway in the cumulus cells. This study was undertaken
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to explore the expression of WNT/β-CATENIN signaling proteins, the interaction of
WNTs and FZD receptors, and the possible function of β-CATENIN in human
cumulus cells.

Materials and Methods
110

Cumulus cell culture
The acquisition and use of human cumulus cells was approved by the Health Sciences
Research Ethics Board of the University of Western Ontario and all patients gave

6

informed consent. Cumulus granulosa cells were collected from oocytes being
prepared for intracytoplasmic sperm injection (ICSI) as previously described (Wang et
115

al., 2008). The cells were washed twice with culture medium consisting of
DMEM/F12 (1:1) supplemented with 10% fetal bovine serum (FBS), 100 units/mL
penicillin and 100 µg/mL streptomycin. The cells were grown on glass coverslips
treated with 0.358 mg/mL collagen (BD Biosciences, Mississauga, ON, Canada) and
cultured at 37°C, 5% CO2 in air for 24 hours. Cumulus cells from individual follicles
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were cultured separately. All products for this study were purchased from Invitrogen
Canada Inc. (Burlington, ON) unless specifically mentioned.

Immunofluorescence microscopy
Information for all antibodies used in this study is listed in Table 1. As a positive
125

control for each antibody, we also used it to stain mouse ovaries by
immunohistochemistry. Cells grown on glass coverslips were fixed with pre-chilled
methanol/acetone (4:1) at 4°C for 20 min and then rinsed with phosphate-buffered
saline (PBS) to prepare them for immunostaining. Briefly, the cells were blocked with
washing buffer containing 3% w/v bovine serum albumin (BSA) for 1 h,
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immunolabeled with primary antibody for 1 h, washed with PBS, and immunolabeled
with appropriate secondary antibody for 1 h in the dark. For double-immunolabeling,
cells were treated with the first primary antibody for 1 h and then with Alexa Fluor
594-conjugated secondary antibody for 1 h, followed by treatment with the second
primary antibody for 1 h and finally by an Alexa Fluor 488-conjugated secondary

7
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antibody. Several washes were interposed between the different antibody incubations.
Cells were washed in PBS and the nuclei stained with 0.1% Hoechst for 10 min
followed by washes with PBS and double distilled H2O. The coverslips were mounted
on slides with Airvol (Air Products & Chemicals, Inc., Allentown, PA, USA) before
storage at 4°C. At least 50 patients contributed cumulus cells for this study, with at
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least 5 coverslips from each patient being analyzed by immunostaining with each
antibody. The cells were imaged using a Zeiss (Thornwood, NY) LSM 510 META
confocal microscope. Fluorescent signals were captured after excitation with 488, 543,
or 730 nm laser lines. Digital images were prepared using Zeiss LSM and Adobe
Photoshop 7.0 software.
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Co-immunoprecipitation
Cumulus cells from all follicles of one or two patients collected on the same day were
pooled for these analyses. Cumulus cells were lysed in immunoprecipitation (IP)
buffer [125 mM NaCl, 20 mM Tris-Cl (pH 7.5), 1% Triton-X-100, 2 mM EDTA, 1
150

mM Na3VO4, 1 mM NaF, and 1X protease inhibitor cocktail (Roche, Mannheim,
Germany)]. Five-hundred µg total proteins were incubated with 3-5 µg of antibody
against WNT2, FZD2, FZD3, FZD9 or CDH1 in 1.0 ml IP buffer on a rocker at 4°C
overnight. The antibodies were precipitated with 50 µl of Dynabeads® Protein G for 2
hours on a rocker at 4°C. The beads were washed twice with washing buffer (25 mM
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citric acid, 50 mM Na2HPO4, pH 5.0) and then eluted with 0.1 M citrate (pH 2-3). Fifty
µg total protein before immunoprecipitation was set as the input sample, while the

8

sample without antibody incubation was considered as negative control.

Immunoblotting
160

All samples were boiled for 5 minutes and loaded on 12% SDS-PAGE gels. The
proteins were transferred to nitrocellulose membrane (Amersham Pharmacia Biotech,
Little Chalfout, Buckinghamshire, England). The membrane was blocked with 5%
nonfat milk (w/v) in Tris-buffered saline Tween-20 (TBST) for 1 h, and subsequently
probed with specific primary antibody other than the immunoprecipitating antibody
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overnight at 4°C followed by incubation with infrared fluorescent-labeled secondary
antibody (Alexa-680 anti-rabbit, anti-goat or anti-mouse). Antibody binding was
detected by use of the Odyssey infrared-imaging system (LI-COR Biosciences,
Lincoln, NE). The membrane was stripped and re-probed with the same antibody used
for
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immunoprecipitation,

then

incubated

with

the

corresponding

infrared

fluorescent-labeled secondary antibody. The immunoblots were processed using
LI-COR. Two washes with TBST were inserted between the antibody treatment steps.

Results
Detection of WNTs and FZDs in human cumulus cells
175

To begin to explore WNT signaling in human cumulus cells, we looked for the
expression of WNT1, WNT2, and WNT4. The results showed that WNT2 is expressed
in cumulus cells, but WNT1 and WNT4 were not detected (Fig. 1A). The same WNT1
antibody revealed strong immunoreactivity in oocytes and corpora lutea of mouse
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ovaries but the WNT4 antibody did not reveal any distinct immunoreactivity (H.-X.
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Wang and G.M. Kidder, manuscript in preparation). It has been reported that FZD2,
FZD3, FZD4 and FZD9 are potential receptors for WNT2 in Drosophila or
mammalian cells (Wu and Nusse, 2002; Klein et al., 2008; Karasawa et al., 2002). In
our study, FZD2, FZD3, and FZD9 but not FZD4 were detected (Fig. 1B); again, the
FZD4 antibody did reveal expression of this protein in mouse oocytes and corpora
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lutea (H.-X. Wang and G.M. Kidder, manuscript in preparation). FZD2 is localized
mainly in the cytoplasm (see also Fig. 2A showing colocalization with cytoplasmic
WNT2), whereas FZD3 and FZD9 are localized in the cytoplasm and membranes.

Interaction of WNT2 and its possible receptors
190

We used double-label immunofluorescence to explore the co-localization of WNT2
and FZDs in human cumulus cells. We found that WNT2 is co-expressed with each of
FZD2, FZD3, and FZD9 (Fig. 2). WNT2 co-localizes with FZD2 in the cytoplasm (Fig.
2A) and with FZD3 and FZD9 in both the membranes and cytoplasm (Fig. 2B and C).
The possibility of direct interaction of WNT2 with the three receptors was then tested
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by co-immunoprecipitation experiments. When cell lysates were immunoprecipitated
with antibody directed against WNT2, FZD3 and FZD9 were also found in the pellet,
but FZD2 was not (Fig. 3A, B, C). Conversely, although WNT2 was precipitated by
FZD9 antibody, FZD2 and FZD3 antibodies were ineffective (Fig. 3D). No protein
bands were evident in cell lysates not treated with immunoprecipitating antibody
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(negative controls in Fig. 3A-D).

10

Expression of WNT2/β-CATENIN signaling proteins in human cumulus cells
As reported previously, FZD9 is activated by WNT2 and functions through the
WNT/β-CATENIN pathway (Karasawa et al., 2002). DVL, AXIN, GSK-3β, and
205

β-CATENIN are four important molecules in this pathway (Gordon and Nusse, 2006).
All four proteins were detected in human cumulus cells by immunofluorescence (Fig.
4). The pattern of immunostaining for DVL, AXIN, and β-CATENIN indicated their
localization in both the cell periphery and the perinuclear cytoplasm, whereas that for
GSK-3β was clearly cytoplasmic. Co-immunolabeling experiments demonstrated that
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DVL colocalizes with FZD9 and AXIN in the membranes (Fig. 5A and B) while
GSK-3β is localized mostly in the cytoplasm, with little colocalization with AXIN or
β-CATENIN (Fig. 5C and D). Interestingly, FZD9 is highly co-localized with
β-CATENIN in the cell membranes (Fig. 5E).
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Localization of β-CATENIN in cumulus cells
As recently reported, activation of the WNT pathway recruits dephosphorylated
β-CATENIN into the plasma membrane where it colocalizes with two members of the
destruction complex, APC and AXIN (Hendriksen et al., 2008). Our results indicate
that AXIN is highly localized with β-CATENIN in the cytoplasm of cumulus cells (Fig.
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6A). As a component of adherens junctions, β-CATENIN promotes cell adhesion by
binding to the intracellular domain of the transmembrane protein, epithelial cadherin
(CDH1) (Bienz, 2005). CDH1 was also detected in human cumulus cells, with some
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junction-like plaques being found between the cells (arrows in Fig. 6B).
Co-immunoprecipitation confirmed that β-CATENIN interacts with CDH1 in human
225

cumulus cells (Fig. 6C). Co-immunolabeling further confirmed that CDH1
co-localizes with β-CATENIN to a limited extent in the membranes (Fig. 6D).

Discussion
WNTs comprise a large family of secreted glycoproteins that are responsible for key
230

developmental processes including cell proliferation, cell polarity, and cell fate
determination. Conventional WNT signaling causes β-CATENIN accumulation in a
complex with the transcription factor TCF/LEF that regulates target gene expression
(Wodarz and Nusse, 1998; Hoppler and Kavanagh, 2007). Dysregulation of WNT
signaling is linked to a range of diseases, most notably cancer (Logan and Nusse,
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2004). A few reports have indicated that WNT signaling plays a key role in
development of the ovary, and WNT pathway components are normally expressed in
ovarian granulosa cells (Vionio et al., 1999; Hsieh et al., 2005; Ricken et al., 2002;
Hsieh et al., 2002). Aberrant WNT signaling leads to granulosa cell tumorigenesis
(Boerboom et al., 2005). These findings suggest that WNT signaling is important for
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follicular development. However, we know little about WNT signaling in human
ovarian follicles and its roles in folliculogenesis. It was thus important to explore the
expression of WNT signaling components in human cumulus cells.
Previous experiments revealed that WNT2 mRNA is concentrated in the cumulus
granulosa cells of rat ovaries and that WNT4 mRNA is expressed in small growing

12
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follicles and corpora lutea of mouse ovaries (Ricken et al., 2002; Hsieh et al., 2002). In
the present study, we only detected the expression of WNT2 in human cumulus cells;
WNT1 and WNT4 were not detected. Neither of the two different WNT4 antibodies
we used, both of which have been successfully used by others, revealed the presence of
this protein in mouse ovaries either. We are unaware of any report confirming
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expression of WNT4 in adult ovaries at the protein level. Therefore, we think it
unlikely that WNT4 is present in our human cumulus cell samples, although some
uncertainty still exists. Since WNT4 might function to regulate earlier stages of follicle
growth, and cumulus cells from ISCI patients are mostly retrieved from large mature
follicles, the absence of WNT4 is perhaps not surprising.
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To verify that the WNT2 signaling pathway is intact in cumulus cells, we looked
for the presence of possible receptors. It has been demonstrated that FZD2 and FZD3
interact with WNT2 in Drosophila (Wu and Nusse, 2002), that FZD4 is the receptor
for WNT2 in rat hepatic sinusoidal endothelial cells and human colon-derived cells
(Klein et al., 2008; Planutis et al., 2007), and that FZD9 is activated by WNT2 in
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transfected 293 cells (Karasawa et al., 2002). FZD4 was only found in rat but not
mouse granulosa cells (Ricken et al., 2002; Hsieh et al., 2002). Here we confirmed the
expression of FZD2, FZD3, and FZD9 but failed to find FZD4 in human cumulus cells.
FZD4 plays an essential role in the mouse ovary since Fzd4 null mice are infertile and
exhibit impaired corpus luteum formation and function (Hsieh et al., 2005); if FZD4 is
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similarly involved in human folliculogenesis, its expression must be restricted to the
mural granulosa cells or activated only after ovulation. Co-expression and
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co-immunoprecipitation experiments demonstrated that WNT2 interacts with FZD3
and FZD9 in human cumulus cells, but since only FZD9 antibody could
immunoprecipitate WNT2, it must be considered the most likely receptor candidate.
270

Although the WNT2 antibody had weak ability to precipitate FZD3, two different
FZD3 antibodies failed to precipitate WNT2. One possible explanation for these
results is that WNT2 associates only weakly or infrequently with FZD3 in cumulus
cells. Further study is needed to determine whether FZD3 is another potential receptor
for WNT2 in human cumulus cells.
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It has been demonstrated that FZD and DVL are essential in both the canonical and
noncanonical WNT pathways. In transfected 293 cells, FZD9 is activated by WNT2
and functions through the β-CATENIN pathway (Karasawa et al., 2002). β- CATENIN
is a key effector of WNT/β-CATENIN signaling and is regulated by the cytoplasmic
destruction complex formed by AXIN, GSK-3β, and APC. In this study, we detected
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the expression of DVL, AXIN, GSK-3β, and β-CATENIN in human cumulus cells.
DVL is co-localized with FZD9 and AXIN in the plasma membranes, indicating that
FZD9 can activate the cytoplasmic protein DVL and recruit it into the membrane,
where it then interacts with AXIN. This interpretation is supported by the observations
that overexpression of FZD9 induces the hyperphosphorylation and relocation of
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mouse DVL-1 from the cytoplasm to the cell membrane, and DVL-2 promotes the
recruitment of AXIN to the plasma membrane during WNT signaling (Karasawa et al.,
2002; Schwarz-Romond et al., 2007). Once AXIN is recruited into the membrane, it is
then degraded by proteasomes leading to inhibition of the activity of the destruction
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complex. The activation of DVL also leads to inhibition of GSK-3β, which further
290

contributes to β-CATENIN accumulation (Moon et al., 2004; Schwarz-Romond et al.,
2007). These results directly support our finding that GSK-3β is not co-localized with
AXIN and β-CATENIN in human cumulus cells.
An interesting finding of our study is that β-CATENIN is mostly localized in the
membrane of cumulus cells, and that FZD9 is highly co-localized with β-CATENIN in
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the plasma membrane. These data indicate that FZD9 will activate β-CATENIN and
recruit it into the membrane. In line with this, Hendriksen et al. (2008) have recently
shown that endogenous dephosphorylated β-CATENIN appears on the membrane
upon WNT3A treatment. This translocation occurs independently of CDH1, and
β-CATENIN is co-localized with phospho-LRP6, AXIN, and APC. We also found
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co-localization of AXIN and β-CATENIN in human cumulus cells. However, the
mechanism and function of the recruitment of β-CATENIN into membranes remain
unclear. Aside from its function in WNT signaling, β-CATENIN was initially
discovered by virtue of its role in forming adherens junctions with CDH1 (Nelson and
Nusse, 2004; Brembeck et al., 2006). The expression of CDH1/CATENIN complexes

305

had been identified in the rat ovary, suggesting that this complex might play roles in
follicle development and luteinization (Sundfeldt et al., 2000). In our study, CDH1 was
detected in junction-like plaques between cumulus cells and CDH1 antibody
precipitated β-CATENIN; furthermore, CDH1 co-localized with β-CATENIN in some
cells. Thus, β-CATENIN in cumulus cells may play a role not only in WNT signaling,
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but also in forming adherens junctions with CDH1.

15

In summary, our results are consistent with the possibility that WNT2 signals
through its receptor FZD9 to regulate the β-CATENIN pathway in human cumulus
cells, potentially recruiting β-CATENIN into the plasma membrane and promoting the
formation of adherens junctions involving CDH1. Our recent work with cultured
315

mouse granulosa cells (Wang and Kidder, in preparation) has revealed that WNT2
stimulates proliferation, suggesting that it may also act as a mitogen to promote follicle
growth. Thus, WNT2/β-CATENIN signaling might play an important role in human
folliculogenesis.
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Table I. Details of antibodies used.
Applicationa

Name

Company

Goat anti-WNT1

Santa Cruz

1: 100

Goat anti-WNT2

Santa Cruz

1: 100

Goat anti-WNT4

R&D Systems

1: 100

Rabbit anti-FZD2

Zymed

Rabbit anti-FZD3

Sigma

Goat anti-FZD3

US Biological

1: 500

3.0 µg

Mouse anti-FZD3

Abnova Corporation

1: 1,000

3.0 µg

Rabbit anti-FZD4

Abcam

1: 200

Rabbit anti-FZD9

Abcam

1:200

1: 1,000

Goat anti-FZD9

Santa Cruz

1:100

1: 300

4.0 µg

Rabbit anti-FZD9

MBL International Corp.

1:100

1: 1,000

3.0 µg

Goat anti-DVL

Santa Cruz

1:100

Rabbit anti-DVL

Abcam

1: 100

Goat anti-AXIN

Santa Cruz

1:100

Mouse anti-GSK-3β

Santa Cruz

1: 200

Rabbit anti-β-CATENIN

Chemicon

1:500

1: 1,000

Mouse anti-CDH1

Zymed

1:100

1: 500

Mouse anti-CDH1

Abcam

1: 200

1: 1,000

Alexa Fluor 488 goat anti rabbit

Molecular probes

1:500

Alexa Fluor 488 goat anti mouse

Molecular probes

1:500

Alexa Fluor 488 rabbit anti goat

Molecular probes

1:500

Alexa Fluor 594 goat anti rabbit



IF

IB

IP

1: 200

4.0 µg

1:100

1:400

5.0 µg

1:200

1: 1,000

Molecular probes

1:300



Molecular probes

1:300



Alexa Fluor 680 goat anti rabbit

Molecular probes

1: 10,000

Alexa Fluor 680 donkey anti rabbit

Molecular probes

1: 10,000

Alexa Fluor 680 rabbit anti mouse

Molecular probes

1: 10,000

Alexa Fluor 594 goat anti mouse

a

IF, immunofluorescence; IB, immunoblotting; IP, immunoprecipitation.

5.0 µg

22

Figure legends
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Figure 1. Expression of WNTs and FZDs in human cumulus cells. (A) Strong
immunostaining was observed for WNT2, but WNT1 and WNT4 were not detected. (B)
Potential WNT2 receptors FZD2, FZD3, and FZD9 were detected but FZD4 was not.
Hoechst dye was used for nucleus staining. Scale bars = 50 µm.
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Figure 2. Co-immunolabeling for WNT2 and its potential receptors FZD2, FZD3,
and FZD9 in human cumulus cells. WNT2 colocalizes with FZD2 (A), FZD3 (B), and
FZD9 (C) in individual cells. Hoechst dye was used for nucleus staining. The same
magnification was used for all micrographs; scale bar = 50 µm.
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Figure 3. Co-immunoprecipitation tests for interaction of WNT2 with its potential
receptors. WNT2 antibody immunoprecipitated FZD3 (B) and FZD9 (C) but not FZD2
(A). CoIP: co-immunoprecipitation; IP: immunoprecipitation; IB: immunoblotting. (D)
WNT2 was immunoprecipitated with FZD9 antibody but not with FZD2 or FZD3
antibody.
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Figure 4.

Localization of DVL, AXIN, GSK-3β, and β-CATENIN in human

cumulus cells. Arrows indicate putative membrane staining. Hoechst dye was used for
nucleus staining. The same magnification was used for all micrographs; scale bar = 50
µm.
455
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Figure 5. Co-expression of WNT/β-CATENIN signaling proteins in human cumulus
cells. (A, B) Colocalization of DVL with FZD9 (A) and AXIN (B). (C,D)
Co-expression but limited colocalization of GSK-3β with AXIN (C) and β-CATENIN
(D). (E) Extensive colocalization of FZD9 and β-CATENIN. Hoechst dye was used for
460

nucleus staining. The same magnification was used for all micrographs; scale bar = 50
µm.

Figure 6.

Localization of β-CATENIN in human cumulus cells. (A) Co-localization

of AXIN and β-CATENIN. (B) Expression of CDH1 (arrows indicate junction-like
465

plaques). (C) Immunoprecipitation of β-CATENIN with CDH1 antibody. (D) Limited
colocalization of CDH1 and β-CATENIN. Hoechst dye was used for nucleus staining.
The same magnification was used for all micrographs; scale bar = 50 µm.
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